STABILITY OF ONDANSETRON HYDROCHLORIDE INJECTION IN EXTEMPORANEOUSLY PREPARED ORAL SOLUTIONS

被引:5
作者
GRAHAM, CL
DUKES, GE
FOX, JL
KAO, CF
HAK, LJ
机构
[1] UNIV MARYLAND,SCH PHARM,DEPT CLIN PHARM,20 N PINE ST,BALTIMORE,MD 21201
[2] UNIV N CAROLINA,SCH PHARM,DIV PHARM PRACTICE,CHAPEL HILL,NC 27514
[3] GLAXO INC,CLIN APPLICAT,RES TRIANGLE PK,NC
[4] UNIV TENNESSEE CTR HLTH SCI,DEPT CLIN PHARM,MEMPHIS,TN 38163
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1993年 / 50卷 / 01期
关键词
ANTIEMETICS; BEVERAGES; CHERRY SYRUP; COMPOUNDING; INCOMPATIBILITIES; JUICES; ONDANSETRON HYDROCHLORIDE; STABILITY; STORAGE;
D O I
10.1093/ajhp/50.1.106
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability of ondansetron hydrochloride in extemporaneously prepared oral solutions containing orange juice, cola, or cherry syrup was determined. Solutions were prepared by adding ondansetron hydrochloride to orange juice, cola, or cherry syrup to produce ondansetron concentrations of 0.267 and 0.067 mg/mL in orange juice or cola and 0.533 mg/mL in cherry syrup. The ondansetron concentration in orange juice and cola solutions was assayed at the time of preparation and at 30 minutes and one hour. The cherry syrup solution was stored at both 3-5 and 25-27-degrees-C, with the ondansetron concentration being determined at the time of preparation and daily for seven days. All the solutions were prepared in triplicate. Ondansetron concentrations were measured by stability-indicating high-performance liquid chromatography. At each time interval, the mean ondansetron concentration remained greater-than-or-equal-to 97% of the initial measurement for all solutions. The appearance and color of the solutions did not change. Ondansetron hydrochloride was stable for at least one hour in orange juice or cola and at least seven days in cherry syrup.
引用
收藏
页码:106 / 108
页数:3
相关论文
共 7 条
  • [1] COLTHUP PV, 1989, EUR J CANCER CLIN ON, V25, pS71
  • [2] FOX J, 1991, NEW ENGL J MED, V325, P1315
  • [3] EVALUATION OF 3 ORAL DOSAGES OF ONDANSETRON IN THE PREVENTION OF NAUSEA AND EMESIS ASSOCIATED WITH CYCLOPHOSPHAMIDE-DOXORUBICIN CHEMOTHERAPY
    FRASCHINI, G
    CIOCIOLA, A
    ESPARZA, L
    TEMPLETON, D
    HOLMES, FA
    WALTERS, RS
    HORTOBAGYI, GN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1268 - 1274
  • [4] STABILITY OF ONDANSETRON IN LARGE-VOLUME PARENTERAL SOLUTIONS
    GRAHAM, CL
    DUKES, GE
    KAO, CF
    BERTCH, JM
    HAK, LJ
    [J]. ANNALS OF PHARMACOTHERAPY, 1992, 26 (06) : 768 - 771
  • [5] ORAL ONDANSETRON
    OSTER, MW
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (03) : 233 - 233
  • [6] AVOIDING COMMON FLAWS IN STABILITY AND COMPATIBILITY STUDIES OF INJECTABLE DRUGS
    TRISSEL, LA
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (07): : 1159 - 1160
  • [7] 1991, ZOFRAN PACKAGE INSER